Quantcast

Latest Hematopoietic stem cell transplantation Stories

2014-03-17 08:29:24

NCI study to investigate whether third generation CAR T Cells can be eliminated if they become harmful HOUSTON, March 17, 2014 /PRNewswire/ -- Bellicum Pharmaceuticals, Inc. announced today that the first clinical study is underway of a Chimeric Antigen Receptor (CAR) T Cell therapy that incorporates a safety switch to enable rapid elimination of the administered T cells if they threaten the life or health of the patient. Researchers from the National Cancer Institute (NCI) have...

2014-03-07 23:21:07

OTTR™ Chronic Care Solutions, the leader in transplant patient tracking and data management software, is proud to announce that they have received official certification from the Center for International Blood and Marrow Transplant Research (CIBMTR) and the National Marrow Donor Program (NMDP) to submit, and retrieve, data using the AGNIS application and framework. Omaha, NE (PRWEB) March 07, 2014 The CIBMTR provides a unique resource of data for addressing important issues in...

2014-03-07 16:22:42

PHOENIX, March 7, 2014 /PRNewswire-USNewswire/ -- Stem cell transplant was viable and effective in halting or reversing degenerative disc disease of the spine, a meta-analysis of animal studies showed, in a development expected to open up research in humans. Recent developments in stem cell research have made it possible to assess its effect on intervertebral disc (IVD) height, Mayo Clinic researchers reported in a scientific poster today at the 30(th) Annual Meeting of the American...

2014-03-05 23:21:24

CNI College announces the Blood and Marrow Drive it will host with St. Joseph Hospital on March 13 at the CNI College campus. This drive is to help Sofia Flores, a 23-month-old AML patient, find a bone marrow match in order to help her combat acute myeloid leukemia, an aggressive form of leukemia. Orange, CA (PRWEB) March 05, 2014 CNI College, a healthcare career college, announces the Blood and Marrow Drive it will host with St. Joseph Hospital on March 13 at the CNI College campus. This...

2014-02-26 08:29:53

SAN BRUNO, Calif., Feb. 26, 2014 /PRNewswire/ -- Cord Blood Registry® (CBR®) announces that the company's abstract submission titled Prevalence of Diseases and Conditions Amenable to Stem Cell Transplant or Infusion Among Families Storing Newborn Stem Cells at a Large Private Cord Blood Bank has been accepted for poster presentation at the combined annual meetings of the Center for International Blood and Marrow Transplant Research (CIBMTR) and the American Society of Blood and...

2014-02-25 08:30:28

LOS ANGELES, Feb. 25, 2014 /PRNewswire/ -- FamilyCord, a subsidiary of California Cryobank, now provides direct cord blood and cord tissue services to Venezuelan families and has assumed management of clients of Cordon de Vida, one of Venezuela's largest cord blood banks. FamilyCord has already been processing and storing Cordon de Vida's cord blood units at their state-of-the-art facility in Los Angeles, California. "We have developed a wonderful working relationship with the...

2014-02-24 12:26:25

GRAPEVINE, Texas, Feb. 24, 2014 /PRNewswire-USNewswire/ -- Just 10 years ago, older patients were typically considered ineligible to receive a blood or bone marrow transplantation (BMT) to treat their blood cancer, but today, patients age 65 and older not only qualify for BMT therapy but are the fastest growing group of recipients. This was reported at the American Society for Blood and Marrow Transplantation (ASBMT) annual meeting as it celebrates its 20(th) anniversary and reflects...

2014-02-20 23:25:03

A European study of compounds designed to stimulate stem cells finds that biologically similar versions work as well as the original. Raleigh, NC (PRWEB) February 20, 2014 A study published in the journal Theranostics and reported by the Non-Hodgkin’s Lymphoma Center finds that a class of drugs that stimulate stem cell production in patients and donors is safe to use. The drugs are biologically similar to granulocyte colony stimulating factor (G-CSF), a human glycoprotein that...

2014-02-18 09:01:07

A new study describes the complexity of the new T cell repertoire following immune-depleting therapy to treat multiple sclerosis, improving our understanding of immune tolerance and clinical outcomes. In the Immune Tolerance Network's (ITN) HALT-MS study, 24 patients with relapsing, remitting multiple sclerosis received high-dose immunosuppression followed by a transplant of their own stem cells, called an autologous stem cell transplant, to potentially reprogram the immune system so that...

2014-02-18 08:31:32

Met Primary Endpoint of Statistically Significant Reduction in Mouth and Throat Soreness Associated With Oral Mucositis; MuGard Patients Also Had Decreased Severity of Oral Mucositis by WHO Score NEW YORK, Feb. 18, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced the online early publication of the final results of its post-approval marketing study of MuGard(®) in Cancer, the journal of the American Cancer Society and one of the oldest peer-reviewed journals...


Latest Hematopoietic stem cell transplantation Reference Libraries

Bone Marrow Transplantation (journal)
2012-06-04 20:00:41

Bone Marrow Transplantation is a peer-reviewed medical journal published monthly by Nature Publishing Group. As of May 2012, the editor-in-chief is J.M. Goldman (UK). The journal publishes high quality, original research that addresses all aspects of basic biology and clinical use of haemopoietic stem cell transplantation in humans. The broad scope of the journal thus encompasses topics such as stem cell biology, kinetics and cytokine control, transplantation immunology, HLA and matching...

More Articles (1 articles) »
Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related